To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID
Clinical trial NCT05911009 · COMPLETED
Trial details
- NCT number
- NCT05911009
- Sponsor
- Berlin Cures GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-16
- Primary completion
- 2024-06-26
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.